Search Results for:

A scientific team led by the Gladstone Institutes and UC […]

Conditions which may accelerate the spread of Parkinson’s disease, and […]

French research into the impact of a premature menopause (less […]

The three Dementia Challenge Champion Groups have written brief reports […]

A glucagon-like peptide-1 agonist (GLP-1 agonist) medication, Exenatide, marketed as […]

Are patients with Parkinson’s disease “blind to blindsight?” That’s not […]

A recent study conducted by researchers from the Mayo Clinic […]

According to the results of the EU FP7-funded REPLACES project […]